Dermatology Times Newsletter

To view this email as a web page, click here.

FDA approves combo treatment for melanoma

Combination that extends survival in BRAF-mutant metastatic melanoma gains FDA approval.

Vermilion lip carcinoma five times more sensitive to metastasis

Chance of metastasis for cutaneous squamous cell carcinomas of vermillion lip is five times greater than on the cutaneous lip, study shows.

Low recurrence of lentigo maligna with off-label neoadjuvant imiquimod use

Two to three months of neoadjuvant topical imiquimod, 5%, cream prior to conservatively staged excisions for lentigo maligna (LM) is associated with a low rate of recurrence.

JOB OPPORTUNITIES

AZ - Integrated Dermatology

CA - Integrated Dermatology

CO - Leavitt Management Group

CT - Integrated Dermatology

District of Columbia - Integrated Dermatology

FL - Integrated Dermatology

FL - Leavitt Management Group

FL - Palm Beach Dermatology

GA - Leavitt Management Group

ID - Integrated Dermatology

MA - Integrated Dermatology

MD - Integrated Dermatology

MI - Leavitt Management Group

MS - Integrated Dermatology

NJ - Integrated Dermatology

NV - Integrated Dermatology

PA - Leavitt Management Group

PA - Integrated Dermatology

PA - Milton S Hershey Medical Center

RI - Leavitt Management Group

TN - Integrated Dermatology

VA - Integrated Dermatology

WY - Leavitt Management Group

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.

CONNECT